SCHEMBL2482279

SCHEMBL2482279

Nc1ccc2c3c(cccc13)C(=O)N(c1ccccc1)C2=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 12/20 1.00
KMT2A Q03164 12/20 1.00
KEAP1 Q14145 8/20 1.00
NFE2L2 Q16236 8/20 1.00
MAPT P10636 6/20 1.00
KDM4E B2RXH2 5/20 1.00
ALDH1A1 P00352 4/20 1.00
HTT P42858 4/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
MEN1 O00255 11/20 0.76
L3MBTL1 Q9Y468 3/20 0.72
RECQL P46063 6/20 0.64
POLB P06746 3/20 0.64
TDP1 Q9NUW8 3/20 0.64
CASP6 P55212 2/20 0.64
APOBEC3A P31941 1/20 0.64
APOBEC3G Q9HC16 1/20 0.64
ATM Q13315 3/20 0.64
HSPA1A P0DMV8 1/20 0.61
PABPC1 P11940 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29353566 1.00 USP2 (1.00) USP2KMT2AKEAP1NFE2L2MAPT
SCHEMBL20735090 0.86 KMT2A (0.76) USP2KMT2AKEAP1NFE2L2MAPT
SCHEMBL2477451 0.86 KMT2A (0.76) USP2KMT2AKEAP1NFE2L2MAPT
SCHEMBL7650466 0.83 KMT2A (0.70) USP2KMT2AKEAP1NFE2L2MAPT
SCHEMBL20735068 0.82 KMT2A (0.69) USP2KMT2AKEAP1NFE2L2MAPT
SCHEMBL20735208 0.82 KMT2A (0.69) USP2KMT2AKEAP1NFE2L2MAPT
SCHEMBL20735113 0.82 KMT2A (0.69) USP2KMT2AKEAP1NFE2L2MAPT
SCHEMBL12526068 0.82 KMT2A (0.69) USP2KMT2AKEAP1NFE2L2MAPT
SCHEMBL16449728 0.82 KMT2A (0.82) USP2KMT2AKEAP1NFE2L2MAPT
SCHEMBL20735409 0.81 KMT2A (0.68) USP2KMT2AKEAP1NFE2L2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101941315-B Method for preparing fluorescence detection membrane containing dual-bandgap photonic crystals for fluorescence detection of explosives CHINESE ACAD INST CHEMISTRY 2012-11-28 CN claimed
CN-101941315-A Method for preparing fluorescence detection membrane containing dual-bandgap photonic crystals for fluorescence detection of explosives CHINESE ACAD INST CHEMISTRY 2011-01-12 CN claimed
CN-113272011-B Methods, devices and compositions for measuring and inducing intercellular communication and therapeutic uses thereof 免疫之光有限责任公司 2024-07-12 CN disclosed
US-20240216713-A1 ENERGY AUGMENTATION STRUCTURES FOR USE WITH ENERGY EMITTERS AND COLLECTORS IMMUNOLIGHT, LLC (US) 2024-07-04 US disclosed
US-11998760-B2 Energy augmentation structures and their use in solar cells and other energy conversion devices IMMUNOLIGHT, LLC (US) 2024-06-04 US disclosed
US-11964167-B2 Energy augmentation structures for use with energy emitters and collectors IMMUNOLIGHT, LLC (US) 2024-04-23 US disclosed
US-11964166-B2 Energy augmentation structures, and their use in adhesive bonding IMMUNOLIGHT, LLC (US) 2024-04-23 US disclosed
US-20240115878-A1 ENERGY AUGMENTATION STRUCTURES, ENERGY EMITTERS OR ENERGY COLLECTORS CONTAINING THE SAME, AND THEIR USE IN SOLAR CELLS AND OTHER ENERGY CONVERSION DEVICES IMMUNOLIGHT, LLC (US) 2024-04-11 US disclosed
US-20240091555-A1 METHODS, DEVICES, AND COMPOSITIONS FOR MEASURING AND INDUCING CELL-TO-CELL COMMUNICATION, AND THERAPEUTIC USES THEREOF IMMUNOLIGHT LLC (US) 2024-03-21 US disclosed
WO-2024050238-A1 METHODS OF IMPROVING EMISSION OUTPUT OF COATED ENERGY MODULATION AGENTS AND COMPOSITIONS PRODUCED THEREBY IMMUNOLIGHT, LLC (US) 2024-03-07 WO disclosed
WO-2024044619-A2 METHODS OF AND DEVICES/APPARATUS FOR DETECTING, TRIGGERING, AND USING CELL-TO-CELL COMMUNICATION IMMUNOLIGHT, LLC (US) 2024-02-29 WO disclosed
CN-101941315-B Method for preparing fluorescence detection membrane containing dual-bandgap photonic crystals for fluorescence detection of explosives CHINESE ACAD INST CHEMISTRY 2012-11-28 CN disclosed
EP-2057123-B1 ANTHRAPYRIDONE COMPOUNDS SABIC INNOVATIVE PLASTICS IP (NL) 2011-10-19 EP disclosed
CN-101941315-A Method for preparing fluorescence detection membrane containing dual-bandgap photonic crystals for fluorescence detection of explosives CHINESE ACAD INST CHEMISTRY 2011-01-12 CN disclosed
US-7812076-B2 Anthrapyridone compounds SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-10-12 US disclosed
CN-100593713-C High sensitivity photon-containing crystal explosive fluorescent checking film preparation method CHINESE ACAD INST CHEMISTRY 2010-03-10 CN disclosed
EP-2057123-A1 ANTHRAPYRIDONE COMPOUNDS Sabic Innovative Plastics IP B.V. (NL) 2009-05-13 EP disclosed
CN-101308094-A High sensitivity photon-containing crystal explosive fluorescent checking film preparation method CHINESE ACAD INST CHEMISTRY (CN) 2008-11-19 CN disclosed
US-20080045634-A1 ANTHRAPYRIDONE COMPOUNDS GENERAL ELECTRIC COMPANY (US) 2008-02-21 US disclosed
WO-2008021694-A1 ANTHRAPYRIDONE COMPOUNDS SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240216713-A1 ENERGY AUGMENTATION STRUCTURES FOR USE WITH ENERGY EMITTERS AND COLLECTORS ETFA, SLC25A1, TIMM44 USP2 4403/4885KMT2A 3746/4885KEAP1 2005/4885
US-11998760-B2 Energy augmentation structures and their use in solar cells and other energy conversion devices CRY1, CXCL12, MCU USP2 4451/4885KMT2A 4127/4885KEAP1 2168/4885
US-20240091555-A1 METHODS, DEVICES, AND COMPOSITIONS FOR MEASURING AND INDUCING CELL-TO-CELL COMMUNICATION, AND THERAPEUTIC USES THEREOF CD47, PBK, EPCAM USP2 2893/4885KMT2A 4516/4885KEAP1 2165/4885
US-11964166-B2 Energy augmentation structures, and their use in adhesive bonding FN1, ITGAM, ICAM1 USP2 4414/4885KMT2A 3960/4885KEAP1 3696/4885
US-20240115878-A1 ENERGY AUGMENTATION STRUCTURES, ENERGY EMITTERS OR ENERGY COLLECTORS CONTAINING THE SAME, AND THEIR USE IN SOLAR CELLS AND OTHER ENERGY CONVERSION DEVICES MCU, CRY1, ADIPOR2 USP2 4433/4885KMT2A 4135/4885KEAP1 1708/4885
US-11964167-B2 Energy augmentation structures for use with energy emitters and collectors ETFA, SLC25A1, TIMM44 USP2 4403/4885KMT2A 3746/4885KEAP1 2005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.